---

title: "Temporal dynamics of the plasma proteomic landscape reveals maladaptation in ME/CFS following exertion"
tags:
- üß™ Biomarker
- ‚≠ê Landmark
created: '2025-11-15'
published: '2025-11-15'

---


<details>
<summary>Germain et al. (2025)</summary>

- **Authors:** Arnaud Germain, Katherine A. Glass, Melissa A. Eckert, Ludovic Giloteaux, Maureen R. Hanson.
- **Institutes:** Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York, USA.
- **Publisher:** Molecular & Cellular Proteomics.
- **Link:** [DOI](https://doi.org/10.1016/j.mcpro.2025.101467).

</details>


## Summary

This study provides strong objective evidence for the biological processes underlying PEM. It demonstrates that in ME/CFS patients, the body's response to exercise is "maladaptive," particularly during the 24-hour recovery period. Instead of returning to normal, patients experience persistent and widespread dysregulation of their immune and metabolic systems, including signs of mitochondrial stress. The research successfully links these specific molecular abnormalities to both reduced exercise capacity and hallmark ME/CFS symptoms like muscle pain and sore throat, reinforcing that PEM is a distinct pathological process.

## What was researched?

This study investigated the molecular underpinnings of post-exertional malaise (PEM), the primary symptom of ME/CFS. Researchers performed a detailed, longitudinal analysis of 6,361 unique plasma proteins to see how they change in ME/CFS patients compared to controls following a strenuous exercise challenge designed to induce PEM.

## Why was it researched?

While PEM is the overarching symptom of ME/CFS, the biological mechanisms that cause this exacerbation of symptoms after exertion are unknown. This research aimed to identify objective molecular changes that occur during the recovery period, providing a biological basis for PEM and distinguishing disease-specific changes from those caused by simple physical deconditioning.

## How was it researched?

The study included 132 individuals: 79 ME/CFS patients and 53 age- and BMI-matched sedentary controls. All participants underwent two maximal cardiopulmonary exercise tests (CPETs) separated by a 24-hour recovery period. Plasma proteomics were analyzed at four different time points using the Somascan¬Æ 7K assay to monitor protein changes over time.

## What has been found?

The most pronounced proteomic changes were seen in ME/CFS participants during the recovery phase, which coincides with the onset of PEM. Compared to controls, ME/CFS subjects showed persistent dysregulation of immune, metabolic, and neuromuscular pathways. Key findings included the suppression of T and B cell signaling, downregulation of IL-17 pathways, and an upregulation of glycolysis/gluconeogenesis, which suggests mitochondrial stress and impaired immune recovery. These protein changes were also correlated with symptom severity (like muscle pain, sore throat, and lymph node tenderness) and impaired exercise performance (VO2max).

## Discussion

The authors highlight the strength of their study design, particularly the use of *sedentary* controls, which allowed them to isolate molecular alterations specific to ME/CFS rather than those related to deconditioning. The study also provides valuable new data on the molecular response to exercise in a predominantly female sedentary cohort, a population historically underrepresented in exercise physiology research. Furthermore, the discovery of distinct responses between males and females underscores the importance of considering sex as a biological variable in ME/CFS research.

## Conclusion & Future Work

The authors conclude that dynamic, longitudinal proteomic profiling is a valuable tool for characterizing the maladaptive response to exertion in ME/CFS. The findings provide a molecular foundation for a deeper mechanistic investigation into the pathology of PEM.
